KYV-101 is a novel, fully human anti-CD19 chimeric antigen receptor T-cell therapy.
Benzbromarone, a urate-lowering drug, appeared effective among patients with high serum uric acid levels who had no evidence of gout flares.
Cancer patients with biomarker-positive tumors have better outcomes on immune checkpoint inhibitor therapy, a meta-analysis suggests.
DMI algorithm using optical coherence tomography angiography images predicts diabetic retinopathy progression, DME development, visual acuity deterioration.
Lower incidence of total knee replacement, total hip replacement seen with use of colchicine 0.5mg daily.
Small reduction in mortality seen with use of hydrocortisone with fludrocortisone
Lynparza is a poly polymerase inhibitor.
The combination antibiotic consists of aztreonam, a monobactam β-lactam and avibactam, a broad-spectrum β-lactamase inhibitor.
Abrysvo is expected to be available in the third quarter of 2023.
While absolute risk difference is small, higher risk seen for both deep vein thrombosis and pulmonary embolism.
Want to read more?
Please login or register first to view this content.